Analyst Ratings for Eikon Therapeutics Inc. (EIKN)
EIKN Rating Summary
EIKN Price Target Summary
- Highest: $34.00 (BofA Securities)
- Lowest: $7.00 (Wedbush)
- Average: $25.60
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$25.60 (+166.4%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
Avg. $ Target:
$25.60 (+166.4%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/2/2026 | Cantor Fitzgerald » Updated 6/2/2026 |
Imogen Mansfield | New Coverage | Overweight (N/A) |
N/A (N/A) |
13.78 (9.61) |
-30.26% | Details |
| 3/2/2026 | BofA Securities | Jason Zemansky | New Coverage | Buy (N/A) |
34.00 (N/A) |
13.78 (9.61) |
-30.26% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
